Innate PharmaIPH 
$2.281.23%24h
1.23%24h
Global rank17873
Market cap$183.71M
Change 7d-1.44%
YTD Performance-22.05%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Innate Pharma (IPH)
As of November 2024, Innate Pharma has a market cap of $183.71M. This makes Innate Pharma the world's 17873th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Innate Pharma from 2006 to 2024
-
Value:-
Market cap history of Innate Pharma from 2006 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $207.01M | -11.83% |
| 2023 | $234.79M | -20.36% |
| 2022 | $294.83M | -26.03% |
| 2021 | $398.61M | 28.48% |
| 2020 | $310.25M | -41.91% |
| 2019 | $534.11M | -19.84% |
| 2018 | $666.29M | 56.53% |
| 2017 | $425.67M | -67.49% |
| 2016 | $1.31B | 6.25% |
| 2015 | $1.23B | 74.05% |
| 2014 | $707.96M | 59.27% |
| 2013 | $444.49M | 130.70% |
| 2012 | $192.67M | 56.93% |
| 2011 | $122.77M | 17.09% |
| 2010 | $104.85M | -51.45% |
| 2009 | $215.97M | 74.64% |
| 2008 | $123.67M | -62.19% |
| 2007 | $327.10M | -41.60% |
| 2006 | $560.10M | - |
IPH Market Cap Today is $183.71M 1.23% - 21 Nov 2024
View largest stocks by market cap 
